Focus: Ossium Health is a Series A-stage cell therapy biotech specializing in bone marrow-derived stem cells for musculoskeletal and hematologic indications. The Indianapolis-based company operates at mid-scale (201–500 employees) and has been recognized by Forbes as a Next Billion-Dollar Startup candidate (2026).
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Stable — net -1 jobs in 30d
2 added, 3 removed. Backfill posture.
Ossium is a high-risk, high-reward Series A play best suited for scientists and operators comfortable with extended pre-revenue timelines in exchange for early equity upside and exposure to novel stem cell technology.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Ossium Health
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Ossium Health's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Ossium Health CEO Kevin Caldwell Wins 2026 Biocom Catalyst Award - The Manila Times
Ossium Health CEO Kevin Caldwell Wins 2026 Biocom Catalyst Award The Manila Times
Ossium Health Data on On-Demand Organ Donor Bone Marrow Selected as a Top Poster at the 2026 AABB Annual Meeting - The Manila Times
Ossium Health Data on On-Demand Organ Donor Bone Marrow Selected as a Top Poster at the 2026 AABB Annual Meeting The Manila Times
Ossium Health Hosts U.S. Representative Erin Houchin at Indianapolis Production Facility - BioSpace
Ossium Health Hosts U.S. Representative Erin Houchin at Indianapolis Production Facility BioSpace
Ossium Health Hosts U.S. Representative Erin Houchin at Indianapolis Production Facility - GlobeNewswire
Ossium Health Hosts U.S. Representative Erin Houchin at Indianapolis Production Facility GlobeNewswire
Forbes Names Ossium Health a 2026 Next Billion-Dollar Startup - Business Wire
Forbes Names Ossium Health a 2026 Next Billion-Dollar Startup Business Wire
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo